Meridian Bioscience to Hold Fourth Quarter and Full Year 2021 Financial Results Conference Call on November 12, 2021
Meridian Bioscience (NASDAQ: VIVO) will announce its fourth quarter and full year 2021 financial results on November 12, 2021. The event will feature a conference call at 10:00 a.m. Eastern Time led by CEO Jack Kenny and CFO Bryan Baldasare. A live webcast will be available for investors, alongside a telephone option for participants. Additionally, a recorded version will be accessible for one year post-event. Meridian specializes in diagnostic products across various sectors, providing essential solutions globally.
- Upcoming earnings report on November 12, 2021 could show potential growth metrics.
- Introduction of a live webcast for earnings calls enhances investor engagement.
- None.
CINCINNATI, Oct. 14, 2021 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, will report fourth quarter and full year 2021 financial results Friday, November 12, 2021.
Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and Chief Financial Officer, will host a conference call beginning at 10:00 a.m. Eastern Time to discuss the results and answer questions.
Meridian is introducing a live webcast for this and future earnings calls. This will provide the best experience for tuning into the discussion. The link to access the webcast can be found at investor.meridianbioscience.com or directly here.
If you are unable to join the webcast, you may join by telephone. From the U.S., dial (877) 407-0890, or from outside the U.S., dial (201) 389-0918, and provide the code 13724028.
A replay of the conference call will also be available by webcast for 1 year beginning 1:00 p.m. Eastern Time on November 12, 2021 using the link provided at investor.meridianbiocience.com.
About Meridian Bioscience, Inc.
Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.
Meridian's shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian's website address is www.meridianbioscience.com.
Contact:
Charlie Wood
Vice President – Investor Relations
Meridian Bioscience, Inc.
Phone: +1 513.271.3700
Email: mbi@meridianbioscience.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/meridian-bioscience-to-hold-fourth-quarter-and-full-year-2021-financial-results-conference-call-on-november-12-2021-301400640.html
SOURCE Meridian Bioscience Inc
FAQ
When will Meridian Bioscience report its financial results?
What time is the Meridian Bioscience earnings conference call?
Where can I access the Meridian Bioscience earnings call webcast?
Who will host the Meridian Bioscience earnings call?
What is Meridian Bioscience's stock symbol?
